---
$id: https://graph.org.ai/products/commodity/51263135
$type: Product
source: UNSPSC
code: "51263135"
title: "Tertatolol"
class: "51263100"
classTitle: "Adrenergic blocking agent propanolamines"
family: "51260000"
familyTitle: "Adrenergic blocking agents"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Tertatolol

**UNSPSC Code**: 51263135
**Class**: [Adrenergic blocking agent propanolamines](Adrenergic blocking agent propanolamines.mdx)
**Family**: [Adrenergic blocking agents](../Adrenergic blocking agents.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes a beta-adrenergic blocking agent with the molecular formula C16H25NO2S, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 9ZO341YQXP, chemically known as 2-propanol, 1-((3,4-dihydro-2h-1-benzothiopyran-8-yl)oxy)-3-((1,1-dimethylethyl)amino)- but generally known as tertatolol, which bears US NIH Compound Identifier 36920. European Medicines Agency schedules Tertatolol in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB10933MIG. The term TERTATOLOL is an International Non-Proprietary Name. World Health Organization schedules tertatolol in its Anatomical Therapeutic Chemical (ATC) Classification. TERTATOLOL is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule tertatolol under HS 29349990 and SITC 51579. As of Q4 2014, TERTATOLOL remains the US FDA Preferred Term for this commodity. Tertatolol bears US NLM identifiers UMLS ID C0076166 and NCI Concept Code C81654. SMILES: S1C2C(CCC1)CCCC2OCC(O)CNC(C)(C)C.

